Concepedia

Publication | Open Access

PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study

52

Citations

22

References

2022

Year

Abstract

The combination of PD-1 inhibitors with anti-angiogenic therapy and IMRT for HCC is a promising regimen.

References

YearCitations

Page 1